Open Access
Volume 25, Number 4, July-August 2018
Article Number D403
Number of page(s) 4
Section Lipids & Brain IV: Lipids in Alzheimer’s Disease / Lipids & Brain IV : les lipides dans la maladie d’Alzheimer
Published online 29 August 2018
  • Arendt T, Bruckner MK, Mosch B, Losche A. 2010. Selective cell death of hyperploid neurons in Alzheimer’s disease. Am J Pathol 177: 15–20. [CrossRef] [PubMed] [Google Scholar]
  • Binder LI, Frankfurter A, Rebhun LI. 1985. The distribution of tau in the nervous system. J Cell Biol 101: 1371–1378. [Google Scholar]
  • Blacker TS, Mann ZF, Gale JE, et al. 2014. Separating NADH and NADPH fluorescence in live cells and tissues using FLIM. Nature Commun. 5: article number 3936. [CrossRef] [Google Scholar]
  • Bloom GS. 2014. Amyloid-beta and Tau: the Trigger and Bullet in alzheimer disease pathogenesis. JAMA Neurol 71: 505–508. [CrossRef] [PubMed] [Google Scholar]
  • Bomfim TR, Forny-Germano L, Sathler LB, et al. 2012. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Abeta oligomers. J Clin Invest 122: 1339–1353. [CrossRef] [PubMed] [Google Scholar]
  • Claxton A, Baker LD, Hanson A, et al. 2015. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer’s disease dementia. J Alzheimer’s Dis 44: 897–906. [CrossRef] [Google Scholar]
  • Craft S, Claxton A, Baker LD, et al. 2017. Effects of regular and long-acting insulin on cognition and Alzheimer’s disease biomarkers: a pilot clinical trial. J Alzheimer’s Dis 57: 1325–1334. [CrossRef] [Google Scholar]
  • de la Monte SM. 2014. Type 3 diabetes is sporadic Alzheimer’s disease: Mini-review. Eur Neuropsychopharm 24: 1954–1960. [CrossRef] [Google Scholar]
  • Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. 1986. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83: 4913–4917. [CrossRef] [PubMed] [Google Scholar]
  • Ittner LM, Ke YD, Delerue F, et al. 2010. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 142: 387–397. [CrossRef] [PubMed] [Google Scholar]
  • Kang J, Lemaire HG, Unterbeck A, et al. 1987. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733–736. [CrossRef] [PubMed] [Google Scholar]
  • Kondo J, Honda T, Mori H, et al. 1988. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1: 827–834. [CrossRef] [PubMed] [Google Scholar]
  • Kosik KS, Orecchio LD, Binder L, Trojanowski JQ, Lee VMY, Lee G. 1988. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1: 817–825. [CrossRef] [PubMed] [Google Scholar]
  • Li L, Cheung T, Chen J, Herrup K. 2011. A comparative study of five mouse models of Alzheimer’s disease: cell cycle events reveal new insights into neurons at risk for death. Int J Alzheimer’s Dis 2011: article ID 171464. [Google Scholar]
  • Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82: 4245–4249. [CrossRef] [PubMed] [Google Scholar]
  • McShea A, Wahl AF, Smith MA. 1999. Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. Med Hypotheses 52: 525–527. [CrossRef] [PubMed] [Google Scholar]
  • Mosconi L. 2013. Glucose metabolism in normal aging and Alzheimer’s disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging 1: 217–233 [CrossRef] [Google Scholar]
  • Nagy Z, Esiri MM, Cato AM, Smith AD. 1997. Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropathol 94: 6–15. [CrossRef] [PubMed] [Google Scholar]
  • Norambuena A, Wallrabe H, Cao R, et al. 2018. A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-β oligomers. EMBO J: in press [Google Scholar]
  • Norambuena A, Wallrabe H, McMahon L, et al. 2017. mTOR and neuronal cell cycle reentry: how impaired brain insulin signaling promotes Alzheimer’s disease. Alzheimers & Dementia 13: 152–167. [CrossRef] [Google Scholar]
  • Pilz GA, Bottes S, Betizeau M, et al. 2018. Live imaging of neurogenesis in the adult mouse hippocampus. Science 359: 658–662. [CrossRef] [Google Scholar]
  • Seward ME, Swanson E, Norambuena A, et al. 2013. Amyloid-beta signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer’s disease. J Cell Sci 126: 1278–1286. [CrossRef] [Google Scholar]
  • Sorrells SF, Paredes MF, Ebrian-Silla AC, et al. 2018. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature 555: 377–381. [CrossRef] [PubMed] [Google Scholar]
  • Steen E, Terry BM, Rivera EJ, et al. 2005. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease − is this type 3 diabetes? J Alzheimer’s Dis 7: 63–80. [CrossRef] [Google Scholar]
  • Varvel NH, Bhaskar K, Patil AR, Pimplikar SW, Herrup K, Lamb BT. 2008. Abeta oligomers induce neuronal cell cycle events in Alzheimer’s disease. J Neurosci 28: 10786–10793. [CrossRef] [PubMed] [Google Scholar]
  • Villemagne VL, Burnham S, Bourgeat P, et al. 2013. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol 12: 357–367. [CrossRef] [PubMed] [Google Scholar]
  • Weingarten MD, Lockwood AH, Hwo S-Y., Kirschner MW. 1975. A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72: 1858–1862. [CrossRef] [PubMed] [Google Scholar]
  • Yang Y, Mufson EJ, Herrup K. 2003. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease. J Neurosci 23: 2557–2563. [CrossRef] [PubMed] [Google Scholar]
  • Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Rev Mol Cell Biol 12: 21–35. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.